Calendar
Groups
Print Newsletters
Donate to PRO!March 1, 2023
ICBII Update on the Road to the Cure - March 2023
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer RISKS OF STEM CELL TRANSPLANT THERAPY FOR PARKINSON'S DISEASE On February 9, 2023, Magenta Therapeutics reported...
Read More
February 1, 2023
ICBII Update on the Road to the Cure - February 2023
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer STEM CELL THERAPY FOR PARKINSON'S DISEASE There has been a lot of talk recently on social...
January 1, 2023
ICBII UPDATE ON THE ROAD TO THE CURE - JANUARY 2023
A New Potential Therapeutic Target for Parkinson’s Disease Neurodegenerative Parkinson’s disease is characterized by a progressive loss of dopaminergic neurons from the nigrostriatal pathway, formation...
December 1, 2022
ICBII Update on the Road to the Cure - December 2022
A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer EFFORTS TOWARDS A PARKINSON’S CURE The cure of any disease, including Parkinson’s, depends upon two key...
June 30, 2022
ICBII Update on the Road to the Cure - July 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer The Role of LRRK2 in Parkinson’s disease – Mutations in the leucine-rich repeat kinase 2...
April 28, 2022
ICBII UPDATE ON THE ROAD TO THE CURE (May 2022)
Solving the Blood-Brain Barrier Conundrum in CNS Drug Development Last month’s editorial remarks by Jo Rosen being reprinted: in 1998 I was told by Robert...
March 31, 2022
ICBII Update on the Road to the Cure - April 2022
Blood-Brain Barrier Continues to be the Main Thorn in CNS Drug Development Editorial remarks by Jo Rosen: In 1998 I was told by Robert W. Rand,...
January 31, 2022
ICBII Update on the Road to the Cure (February, 2022)
A Unique Approach to Overcome the Deficiencies of Prior Scientific Art Patients may be wondering why there is NO CURE for Parkinson’s disease despite multi-billions...
December 29, 2021
Update on the Road to the Cure - January 2022
A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer ICBII is named among big pharma developing technology to cross the BBB Parkinson’s Cure May Be Closer...
December 1, 2021
UPDATE ON THE ROAD TO THE CURE - DECEMBER 2021
ICBII UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer Updates will resume next year. In the meantime, Ram S. Bhatt,...
November 1, 2021
UPDATE ON THE ROAD TO THE CURE - NOVEMBER 2021
ICBII UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer “… why hundreds of billions of dollars in global research have...
October 1, 2021
UPDATE ON THE ROAD TO THE CURE - OCTOBER 2021
ICBII UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer LA JOLLA, CA / Sept. 22, 2021/PRNewswire/ Innovative California Biosciences International, Inc., (“ICBII”), has...
April 30, 2019
PARKINSON’S DISEASE FORUM GIVES MEDICAL MARIJUANA PLATFORM FOR 1ST TIME
An online survey circulated among physicians who treat Parkinson’s disease found that 80% of their patients had used cannabis to treat their symptoms. Furthermore,...
April 30, 2019
ICBI UPDATE: A New Experimental Brain Stimulation Treatment Shows Promise in Restoring the Movement of Patients with Chronic Parkinson’s disease (PD)
Canadian researchers are developing a new brain stimulation treatment to restore movement in Parkinson’s patients according to which previously housebound patients are now able...
April 10, 2019
ICBI UPDATE A REAL-TIME SCIENCE REPORT MORE HOPE FOR PARKINSON’S CURE
Recently, Stanford researchers were able to improve the cognitive function of older mice after blocking a protein's activity on brain cells known as microglia....
